NGS is setting a new standard in cancer research. http://www.illumina.com/applications/cancer/clinical-cancer-research.html Dr. Platt of MPLN shares her experience, using molecular assays in clinical research, and discusses how MPLN uses NGS to further their oncology and research portfolio. She shares case examples of the molecular usability and analysis options for deep sequencing of tumor samples. Illumina continues to collaborate with leading laboratories to provide focused, complete solutions, powered by NGS. Presenter Dr. Jamie Platt Vice President, Genomic Solutions Molecular Pathology Laboratory Network, Inc. Subscribe to the Illumina video channel. http://www.youtube.com/subscription_center?add_user=IlluminaInc